Novartis is said to be abandoning Ionis heart drug after late-stage trial setback

The Quick Take
Read the full report from the original publisher.
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to Seeking Alpha Market Currents.
Related
Markets
Seaport offers preliminary thoughts on Anthropic stock
Markets
Marmara Holding Updates Articles of Association - TipRanks
Marmara Holding Updates Articles of Association TipRanks
Markets
Binance CFO exits days after catastrophic $6 billion crypto hack
Local
